Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Data Collection by Experiments01:13

Data Collection by Experiments

Data collection is a systematic method of obtaining, observing, measuring, and analyzing accurate information. An experimental study is a standard method of data collection that involves the manipulation of the samples by applying some form of treatment prior to data collection. It refers to manipulating one variable to determine its changes on another variable. The sample subjected to treatment is known as “experimental units.”
An example of the experimental method is a public clinical trial...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Morinda officinalis</i> oligosaccharides ameliorate corticosterone‑induced depression‑like behaviour in mice by modulating the BDNF signalling pathway and gut microbiota.

Molecular medicine reports·2026
Same author

Assessing county-level high-quality development and spatial adaptation paths under the space of flows perspective: a coupling detrended fluctuation analysis approach.

Scientific reports·2026
Same author

The cost of caring: emotion regulation difficulties mediate burnout and emotional overeating in nurses.

Frontiers in nutrition·2026
Same author

Effects of ambient PM2.5 and its components on the prognosis of colorectal cancer survivors: disease progression and potential mediation pathways.

BMC medicine·2026
Same author

Mixture effects of multiple environmental factors on chronic obstructive pulmonary disease risk Trajectories: Evidence from Pearl River cohort in China.

Environment international·2026
Same author

Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study.

Pituitary·2026

Related Experiment Videos

Detecting data fabrication in clinical trials from cluster analysis perspective.

Xiaoru Wu1, Martin Carlsson

  • 1Department of Statistics, Columbia University, New York, USA. xw2144@columbia.edu

Pharmaceutical Statistics
|October 12, 2010
PubMed
Summary

This study introduces statistical clustering methods to detect data fabrication in clinical trials. These novel approaches identify abnormal patterns, enhancing the integrity of research data.

Related Experiment Videos

Area of Science:

  • Clinical Research
  • Statistical Methodology
  • Data Integrity

Background:

  • Data fabrication poses a significant threat to the reliability of clinical trials.
  • Existing statistical methods for fraud detection often rely on descriptive statistics.
  • Abnormal data patterns in fabricated cases frequently exhibit clustering structures.

Purpose of the Study:

  • To explore the application of statistical clustering methods for detecting data fabrication in clinical trials.
  • To identify and analyze specific clustering patterns indicative of fraud.
  • To develop and validate new statistical tests for fraud detection.

Main Methods:

  • Identification and exploration of three clustering patterns: angular, neighborhood, and repeated measurements clustering.
  • Development of simple and efficient test statistics tailored to these patterns.
  • Utilization of randomization tests to assess the significance of findings.
  • Application of proposed methods to a 12-week multi-center clinical study.

Main Results:

  • The proposed clustering methods effectively identified potential data fabrication in the illustrative study.
  • Simulation studies demonstrated the high sensitivity and specificity of the developed procedures.
  • The identified clustering patterns (angular, neighborhood, repeated measurements) serve as robust indicators of data manipulation.

Conclusions:

  • Statistical clustering methods offer a powerful and efficient approach to detecting data fabrication in clinical trials.
  • The proposed techniques enhance the ability of statisticians to ensure data integrity.
  • Further research and application of these methods can bolster the trustworthiness of clinical trial outcomes.